Abstract:Objective:To detect the expression of miR-199a-3p and phosphatidylinositol 3 kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) in colon cancer tissues and corresponding adjacent tissues, and to explore the relationship between the two and the clinicopathological characteristics of colon cancer.Methods:From January 2016 to July 2019 in Zhongnan Hospital of Wuhan University.Sixty-seven patients with colon cancer diagnosed pathologically were selected, 28 were male and 37 were female among them, with an average age of 63.2 years. The expression of miR-199a-3p and PI3K/Akt/mTOR in colon cancer tissues and adjacent tissues was detected by real-time quantitative reverse transcriptase-polymerase chain reaction (RT-qPCR). The expression of miR-199a-3p in colon cancer patients was detected in according to the difference of some clinicalpathological factors. Correlations among miR-199a-3p, PI3K, Akt, and mTOR protein expression in colon cancer tumor tissues were also analyzed. SPSS 22.0 statistical software was used for analysis, and comparison between groups was performed by χ2 test. Results:The expression level of miR-199a-3p (1.107±0.041) in colon cancer tumor tissues was significantly higher than that in normal adjacent tissues (0.613±0.034) ( t=2.611, P<0.05). The expression of miR-199a-3p in tumor tissues of colon cancer patients was significantly correlated with the clinicopathological factors such as lymphatic invasion ( χ2=8.111, P<0.05), vascular invasion ( χ2=5.550, P<0.05), lymph node metastasis ( χ2=4.189, P<0.05), liver metastasis ( χ2=12.320, P<0.05), and clinical stage ( χ2=4.300, P<0.05), but not with age ( χ2=0.069, P>0.05), gender ( χ2=0.238, P>0.05), tumor location ( χ2=0.321, P>0.05), pathological grade ( χ2=0.013, P>0.05), and peritoneal metastasis ( χ2=0.109, P>0.05). The positive expression rate of mTOR in colon cancer tumor tissue was 80.60% (54/67), significantly higher than that in normal tissues adjacent to the cancer [23.88% (16/67)] ( χ2=43.191, P<0.05). The positive expression rate of Akt in colon cancer tumor tissues was 74.63% (50/67), significantly higher than that of normal tissues adjacent to the cancer [28.36% (19/67)] ( χ2=28.711, P<0.05). The positive expression rate of PI3K in colon cancer tumor tissues was 68.66% (46/67), significantly higher than that in normal adjacent tissues [25.37% (17/67)] ( χ2=25.191, P<0.05). The miR-199a-3p expression in colon cancer tumor tissues was positively correlated with PI3K, Akt, mTOR ( r=0.632, 0.605, 0.689, P<0.05), and PI3K expression in colon cancer tissues was positively correlated with Akt and mTOR ( r=0.707, 0.705, P<0.05). The Akt expression in colon cancer tissues was positively correlated with mTOR ( r=0.647, P<0.05). Conclusion:The expression level of miR-199a-3p in tumor tissues of colon cancer patients was significantly higher than that of adjacent tissues, and significantly related to clinicopathological factors such as lymphatic invasion, vascular invasion, lymph node metastasis, liver metastasis, and clinical stage. There is a positive correlation among miR-199a-3p, PI3K, Akt, and mTOR in colon cancer tissues. The miR-199a-3p, PI3K/Akt/mTOR signaling pathway may play an important role in the occurrence and development of colon cancer.

Novel miR-490-3p/hnRNPA1-b/PKM2 axis mediates the Warburg effect and proliferation of colon cancer cells via the PI3K/AKT pathway

Long non-coding RNA CCAT1 promotes colorectal cancer progression by regulating miR-181a-5p expression

MicroRNA-766-3p-mediated downregulation of HNF4G inhibits proliferation in colorectal cancer cells through the PI3K/AKT pathway

The miR-873/NDFIP1 axis promotes hepatocellular carcinoma growth and metastasis through the AKT/mTOR-mediated Warburg effect.

MiR-1306-5p Predicts Favorable Prognosis and Inhibits Proliferation, Migration, and Invasion of Colorectal Cancer Cells Via PI3K/AKT/mTOR Pathway

Mutual Regulation Of Mir-199a-5p And Hif-1 Alpha Modulates The Warburg Effect In Hepatocellular Carcinoma

MicroRNA‑8063 Targets Heterogeneous Nuclear Ribonucleoprotein AB to Inhibit the Self‑renewal of Colorectal Cancer Stem Cells Via the Wnt/β‑catenin Pathway.

P53-induced Mir-1249 Inhibits Tumor Growth, Metastasis, and Angiogenesis by Targeting VEGFA and HMGA2

Expression and clinical significance of microRNA-199a-3p and phosphatidylinositol 3 kinase/protein kinase B/mammalian target of rapamycin signaling pathway in colon cancer

Mir-124, Mir-137 and Mir-340 Regulate Colorectal Cancer Growth Via Inhibition of the Warburg Effect.

Activation of miR-500a-3p/CDK6 axis suppresses aerobic glycolysis and colorectal cancer progression

Mir-942-5p Inhibits Proliferation, Metastasis, and Epithelial-Mesenchymal Transition in Colorectal Cancer by Targeting CCBE1

Downregulation of DNMT3A Attenuates the Warburg Effect, Proliferation, and Invasion via Promoting the Inhibition of miR-603 on HK2 in Ovarian Cancer

IDDF2018-ABS-0183 P53-induced MIR-1249 suppresses tumour progression by targeting VEGFA and HMGA2 in colorectal cancer

Circ_0004018 suppresses cell proliferation and migration in hepatocellular carcinoma via miR-1197/PTEN/PI3K/AKT signaling pathway

Repressing Phosphatidylinositol-4,5-bisphosphate 3-Kinase Catalytic Subunit Gamma by Microrna-142-3p Restrains the Progression of Hepatocellular Carcinoma

MicroRNA-490-5P targets CCND1 to suppress cellular proliferation in glioma cells and tissue through cell cycle arrest.

MicroRNA-4463 Facilitates the Development of Colon Cancer by Suppression of the Expression of PPP1R12B

MicroRNA-492 expression promotes the progression of hepatic cancer by targeting PTEN

Enhancement of Proliferation and Invasion by Microrna-590-5p Via Targeting Pbrm1 in Clear Cell Renal Carcinoma Cells

Microrna-155-5p Promotes Hepatocellular Carcinoma Progression by Suppressing Pten Through the Pi3k/Akt Pathway